Jacobs Levy Equity Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-29,701
| Closed | -$258K | – | 1138 |
|
|
2018
Q2 | $258K | Sell |
29,701
-3,800
| -11% | -$33K | ﹤0.01% | 918 |
|
|
2018
Q1 | $340K | Sell |
33,501
-5,800
| -15% | -$58.9K | 0.01% | 844 |
|
|
2017
Q4 | $191K | Buy |
39,301
+1,000
| +3% | +$4.86K | ﹤0.01% | 914 |
|
|
2017
Q3 | $174K | Sell |
38,301
-600
| -2% | -$2.73K | ﹤0.01% | 885 |
|
|
2017
Q2 | $196K | Buy |
38,901
+15,411
| +66% | +$77.6K | ﹤0.01% | 847 |
|
|
2017
Q1 | $112K | Sell |
23,490
-900
| -4% | -$4.29K | ﹤0.01% | 855 |
|
|
2016
Q4 | $137K | Sell |
24,390
-200
| -0.8% | -$1.12K | ﹤0.01% | 868 |
|
|
2016
Q3 | $136K | Sell |
24,590
-400
| -2% | -$2.21K | ﹤0.01% | 946 |
|
|
2016
Q2 | $175K | Buy |
+24,990
| New | +$175K | ﹤0.01% | 1032 |
|
|
2015
Q1 | – | Sell |
-51,229
| Closed | -$287K | – | 933 |
|
|
2014
Q4 | $287K | Buy |
+51,229
| New | +$287K | ﹤0.01% | 696 |
|